Shalby Limited has announced a significant expansion of its healthcare services with the inauguration of an Oncology Department along with advanced Radiotherapy facilities at Krishna Shalby Hospital in Ahmedabad. The company disclosed this major development through a regulatory filing under Regulation 30 of SEBI (LODR) Regulations, 2015 on March 23, 2026.

New Oncology Services Launch

The introduction of oncology and radiotherapy services at Krishna Shalby Hospital marks a strategic enhancement in the company's healthcare offerings. The new department is designed to ensure patients have access to comprehensive cancer treatment under one roof, eliminating the need for multiple facility visits.

Comprehensive Cancer Care Team

The newly launched department is supported by an experienced team of specialized medical professionals. The hospital has assembled a multidisciplinary team to provide complete cancer care services:

• Medical oncologists for cancer treatment and chemotherapy
• Radiation oncologists for radiotherapy services
• Surgical oncologists for cancer surgery procedures

This integrated approach enables patients to receive specialized diagnosis and treatment at a single location, streamlining the cancer care process.

Advanced Technology and Patient-Centric Approach

The oncology department leverages advanced technology combined with expert medical teams to deliver effective cancer treatment. The company emphasizes its commitment to a patient-centric approach, focusing on timely diagnosis and effective treatment for patients in and around Ahmedabad.

The launch of these advanced services positions Krishna Shalby Hospital as a comprehensive cancer care provider in the region, offering patients access to modern oncology and radiotherapy facilities without the need to seek treatment at multiple locations.

Shalby Limited has successfully concluded its postal ballot process, with shareholders overwhelmingly approving the re-appointment of Mr. Shyamal Shivkumar Joshi as an Independent Director. The special resolution received strong support from the shareholder community, demonstrating confidence in the director's continued leadership.

Voting Results and Participation

The postal ballot process concluded on March 21, 2026, with results declared on March 23, 2026. The voting demonstrated significant shareholder participation and clear approval for the proposed resolution.

Director Appointment Details

The approved resolution pertains to the re-appointment of Mr. Shyamal Shivkumar Joshi (DIN: 00005766) as an Independent Director for his second consecutive term. This appointment reflects the board's commitment to maintaining experienced independent oversight.

Category-wise Voting Pattern

The voting results revealed distinct patterns across different shareholder categories, with promoters showing unanimous support while institutional and retail investors demonstrated varied responses.

Promoter and Promoter Group:

• Shares held: 8,02,78,373
• Votes polled: 8,02,78,123 (99.9997% participation)
• Support: 100.00% in favor

Public Institutions:

• Shares held: 50,33,137
• Votes polled: 3,50,749 (6.97% participation)
• Support: 0% in favor, 100.00% against

Public Non-Institutions:

• Shares held: 2,26,98,260
• Votes polled: 1,01,239 (0.45% participation)
• Support: 40.94% in favor, 59.06% against

Process and Compliance

The postal ballot was conducted entirely through remote e-voting, utilizing the services of National Securities Depository Limited (NSDL) as the service provider. The process adhered to all regulatory requirements under the Companies Act, 2013 and SEBI regulations.

The e-voting period commenced on February 20, 2026 at 9:00 AM IST and concluded on March 21, 2026 at 5:00 PM IST. Chintan Patel, Company Secretary in Practice, served as the appointed Scrutinizer for the postal ballot process, ensuring fair and transparent conduct of the voting procedure.

The cut-off date for determining eligible shareholders was February 13, 2026, and the postal ballot notice was dispatched electronically to shareholders on February 17, 2026. This appointment strengthens Shalby Limited's board composition with continued independent director expertise for the upcoming five-year term.